X0202 4 2005-06-28 0 0001115285 EYETECH PHARMACEUTICALS INC EYET 0001106607 JP MORGAN PARTNERS BHCA LP C/O J.P. MORGAN PARTNERS, LLC 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001243235 JPMP MASTER FUND MANAGER L P JP MORGAN PARTNERS LLC 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001330534 JPMP CAPITAL CORP 1221 AVENUE OF THE AMERICAS 39TH FLOOR NEW YORK NY 10020 0 0 1 0 Common Stock 2005-06-28 4 A 0 35000 .01 A 2275896 D Director Stock Option (right to buy) 1.44 2002-12-03 2012-12-03 Common Stock 60000 60000 I See footnote Director Stock Option (right to buy) 34.34 2014-05-12 Common Stock 20000 20000 I See footnote Director Stock Option (right to buy) 23.31 2015-05-10 Common Stock 50000 50000 I See footnote These shares of Common Stock were granted to Srinivas Akkaraju and Damion Wicker, directors of the Issuer, pursuant to (1) a Restricted Stock Agreement between Damion E. Wicker and Eyetech Pharmaceuticals, Inc. and (2) a Restricted Stock Agreement between Srinivas Akkaraju and Eyetech Pharmaceuticals, Inc. The stock award shall vest on June 28, 2006. Mr. Wicker and Mr. Akkaraju are obligated to transfer these shares to the Reporting Person, at the request of the Reporting Person. These options were granted to Damion Wicker and Srinivas Akkaraju. Mr. Wicker and Mr. Akkaraju are Managing Directors of JPMP Capital Corp., the general partner of JPMP Master Fund Manager, L.P. ("MF Manager"), the general partner of J.P. Morgan Partners (BHCA), L.P. ("JPM BHCA"). Mr. Wicker and Mr. Akkaraju are obligated to transfer any shares issued under the stock option to JPM BHCA. These options become exercisable on June 12, 2004. They will vest in 48 monthly installments. These options will become exercisable on June 11, 2005. They will vest in 48 monthly installments. J.P. Morgan Partners (BHCA), L.P. By: JPMP Master Fund Manager, L.P., Its general partner By: JPMP Capital Corp., Its general partner By: /s/ Damion E. Wicker Managing Director 2005-06-30